Stephen Archer earns top honour in heart research
This past week, Dr. Stephen Archer travelled to New Orleans to accept a very special honour from one of the world’s most important organizations for cardiovascular health and research: he received the Distinguished Scientist Award from the American Heart Association.
The Distinguished Scientist designation was created in 2003 to honor American Heart Association members who have made extraordinary contributions to cardiovascular and stroke research. The American Heart Association’s Distinguished Scientists are a prominent group of scientists and clinicians whose work has advanced the understanding of cardiovascular diseases and stroke. This prestigious honour is a celebration of Dr. Archer’s lifetime of ground-breaking research and a long list of discoveries that have advanced care for patients with pulmonary hypertension and cancer.
Now a world-renowned cardiologist and scientist, Dr. Archer grew up on the east coast of Canada. He came to Queen’s to study medicine and graduated in 1981. Dr. Archer completed his Internal Medicine Residency and Cardiology Fellowship at the University of Minnesota. He then was a Faculty Cardiologist at the University of Minnesota for ten years. Moving back to Canada in 1998, Dr. Archer served as Chief of Cardiology at the University of Alberta for nine years before moving on to the University of Chicago. After four years serving as Chief of Cardiology there, he returned to Queen’s to take a position as Head of the Department of Medicine at Queen’s. And in his role as head, Dr. Archer has had a transformational impact on the Department of Medicine and its research portfolio. In a few months’ time, the Queen’s CardioPulmonary Unit (Q-CPU) – a state of the art international research unit spearheaded by Dr. Archer – will open its doors on campus.
Dr. Archer holds a Tier 1 Canada Research Chair in Mitochondrial Dynamics and Translational Medicine. He recently received a $4 million CIHR Foundation Award to support a project examining the mechanism of mitochondrial fission with a focus on understanding the interaction between an enzyme called dynamic relate protein 1 (Drp1) and its four binding partners. To learn more about his research read his recent blog post: Targeting Mitochondrial Dynamics to Treat Cancer and Pulmonary Hypertension.
Please share your words of congratulations and thoughts on this award by commenting on the blog, or better yet, drop by Dr. Archer’s office in Etherington Hall…his door is always open.